Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                

Estimating the population-level effects of non-pharmaceutical interventions when transmission rates of COVID-19 vary by orders of magnitude from one contact to another

Richard P. Sear r.sear@surrey.ac.uk School of Mathematics and Physics, University of Surrey, Guildford, GU2 7XH, United Kingdom https://richardsear.me/
Abstract

Statistical physicists have long studied systems where the variable of interest spans many orders of magnitude, the classic example is the relaxation times of glassy materials, which are often found to follow power laws. A power-law dependence has been found for the probability of transmission of COVID-19, as a function of length of time a susceptible person is in contact with an infected person. This is in data from the United Kingdom’s COVID-19 app. The amount of virus in infected people spans many orders of magnitude. Inspired by this I assume that the power-law behaviour found in COVID-19 transmission, is due to the effective transmission rate varying over orders of magnitude from one contact to another. I then use a model from statistical physics to estimate that if a population all wear FFP2/N95 masks, this reduces the effective reproduction number for COVID-19 transmission by a factor of approximately nine.

I The transmission of diseases across the air and Non-Pharmaceutical Interventions

The standard model for the transmission of an airborne infectious disease such as COVID-19 postulates that transmission is a random process where a susceptible person takes up an infectious dose of the virus [1, 2], and becomes infected. This transmission takes place during a contact between an infected and a susceptible person. The contact is a time period of length t𝑡titalic_t, during which the infected and susceptible person are close, for example in the same room. Figure 1 is a schematic illustrating the mechanism of airborne transmission of COVID-19.

Refer to caption
Figure 1: Pair of schematics showing two possible contacts between an infected person (I, left) and a susceptible person (S, right). The evidence is that the transmission of COVID-19 is at least predominantly across the air [3, 4, 5, 6, 7, 8, 9]: an infected person breathes out the SARS-CoV-2 virus in an aerosol of droplets of mucus that contain the virus. The droplets are then carried by air currents towards a susceptible person, who inhales them and becomes infected [4, 3, 5, 8]. In panel (a) the rate of transmission r𝑟ritalic_r is high because an infected person with a high viral load is close to and talking with a susceptible person with high genetic susceptibility to infection. In panel (b) the transmission rate r𝑟ritalic_r is much lower. There the infected person has much less virus (lower viral load) and the susceptible person is across a well ventilated room from the infected person.

If we assume standard Poisson statistics for the inhalation of the virus and becoming infected, we have that the probability of transmission increases with contact time t𝑡titalic_t as

PT(t)=1exp(rt)rtrt1formulae-sequencesubscript𝑃𝑇𝑡1𝑟𝑡similar-to𝑟𝑡much-less-than𝑟𝑡1P_{T}(t)=1-\exp(-rt)\sim rt~{}~{}~{}~{}~{}rt\ll 1italic_P start_POSTSUBSCRIPT italic_T end_POSTSUBSCRIPT ( italic_t ) = 1 - roman_exp ( - italic_r italic_t ) ∼ italic_r italic_t italic_r italic_t ≪ 1 (1)

with r𝑟ritalic_r the rate constant for transmission. For airborne diseases such as COVID-19, as well as flu and tuberculosis (TB), Eq. (1) is usually called the Wells-Riley model [2, 1, 10]. In Eq. (1) we have expanded out the exponential to show that at low infection probabilities, the probability of transmission is predicted to increase linearly with time.

Non-pharmaceutical interventions (NPIs), such as mask wearing typically work via reducing the inhalation rate of virus [11]. For example, wearing an FFP2/N95 mask (respirator) reduces the inhaled dose by a factor of approximately 10 [12, 13, 14, 15]. We want to know by how much does this reduce the probability of transmission PTsubscript𝑃𝑇P_{T}italic_P start_POSTSUBSCRIPT italic_T end_POSTSUBSCRIPT?

If we are recommending an NPI for a population then we will not know what the contact time t𝑡titalic_t or transmission rate r𝑟ritalic_r is. Both may vary widely from one contact to another. This leaves us with the difficult problem of assessing the effectiveness of an intervention when we know neither the transmission rate nor the contact time. To make progress I combine two things. The first is a method to model systems with high variability, here in the transmission rate r𝑟ritalic_r, which I take from statistical physics [16, 17, 18, 19, 20]. The second is a large data set on COVID-19 transmission, taken from the United Kingdom’s National Health Service (NHS) app [21, 22].

Refer to caption
Figure 2: Plot of the exceedance function for the estimated concentration of RNA fragments of the COVID-19 genome, as measured by RT-qPCR. Points are from the study of Takatsuki et al.  [23]. The line is a power-law fit to the tail of the exceedance with an exponent 0.700.70-0.70- 0.70.

II Motivation for expected transmission rates to be highly variable

I start by motivating my assumption that the transmission rate varies over orders of magnitude. Transmission is complex [24]. There are many possible factors that could introduce variability into the rate r𝑟ritalic_r, both from human biology, and from the transport of the virus across the air from one person to another, see Fig. 1. We can break down factors that influence the transmission rate r𝑟ritalic_r into three: 1) infectiousness of the infected person, for example how much virus is in their respiratory tract; 2) transport across the air; 3) susceptibility of person infected. We start with 1) infectiousness.

II.1 Infectiousness

In Fig. 2 I have plotted the exceedance for the distribution of viral loads of people infected with COVID-19. The exceedance E(v)𝐸𝑣E(v)italic_E ( italic_v ) is the probability that the viral load v𝑣vitalic_v exceeds the value v𝑣vitalic_v. The data is from Takatsuki et al.  [23]. Note that the viral load is measured by a procedure that quantifies the amount of a fragment of COVID-19’s genome, via reverse transcription quantitative polymerase chain reaction (RT-qPCR). This is not the same as a measure of the amount of infectious virus present [25]. However Killingley et al.  [26] found an approximately linear relationship between RT-qPCR measurements and a measure of how much viable virus there is, see Appendix A.

The dynamic range of viral loads (as measured by RT-qPCR) is huge: 8 orders of magnitude for the Takatsuki et al.  [23] data. Presumably, those with the highest viral load are most infectious [25], but we lack direct evidence of this.

The large viral-load tails of the exceedance is reasonably well fit by a power law with an exponent of 0.70.7-0.7- 0.7. This corresponds to probability density functions for viral loads that scale as r1.7superscript𝑟1.7r^{-1.7}italic_r start_POSTSUPERSCRIPT - 1.7 end_POSTSUPERSCRIPT, for large viral loads. It is an empirical observation that data that spans many decades is often well approximated by a power law, in particular in the tail of large values, as here [17, 18]. This applies to data in many complex systems, from the economy to earthquakes [17, 18]. In complex systems such as viral infection or the economy, the power law is a simple but approximate empirical model, which can be used to make simple predictions. This is how we will use power law models here.

II.2 Fluid flow

Now we turn to how the virus is transported across the air, factor 2. This transport of infectious particles is most efficient when the infected and susceptible persons are close to each and facing each other [5, 10, 8, 24]. Abkarian and coworkers [5] found that for two people close (0.5less-than-or-similar-toabsent0.5\lesssim 0.5≲ 0.5 to 1 mtimes1meter1\text{\,}\mathrm{m}start_ARG 1 end_ARG start_ARG times end_ARG start_ARG roman_m end_ARG) and facing each other, that one will directly inhale some of the other’s breath. This would be the case for example because they are talking to each other. There, perhaps up to 10%similar-toabsentpercent10\sim 10\%∼ 10 % of the air inhaled by one person, could be air recently exhaled by the other person. This fraction roughly decays as one over the separation up to distances around 2 mtimes2meter2\text{\,}\mathrm{m}start_ARG 2 end_ARG start_ARG times end_ARG start_ARG roman_m end_ARG, beyond which directly exhaled air will mix with room air [5, 27, 28, 29, 30, 8, 24].

For a large well ventilated room, the fraction of room air that has been breathed out by one person (here the infected person) will be much less than 1%. So when a susceptible person shares a room with an infected person, the air breathed out by the infected person could constitute anywhere between much less than 1%, and approximately 10% of the air the susceptible person is breathing in.

The air that we breathe out is saturated with water vapour, at 100% relative humidity (RH). For transmission across a room, the air of an infected person’s breath mixes with room air as it crosses the room, and before being breathed in by a susceptible person. As the breath air mixes with room air, the RH drops sharply. From the near 100% RH of breath to the typically close to 50% RH of a room. This partial drying out inactivates a variable fraction of the virus SARS-CoV-2 [31, 32]. So the combination of the dilution of the virus-carrying breath of an infected person, and viral inactivation, can cause the concentration of active virus in the air to vary over orders of magnitude.

II.3 Susceptibility

There is evidence for variability in susceptibility to infection, susceptibility may greatly from one person to another. Part of this is due to genetic differences between one person and another [33, 34, 35]. In addition, susceptibility may vary with age [36], and it will be higher in those with immunodeficiencies [37, 38]. Vaccination reduces but does not eliminate susceptibility, by an amount that depends on vaccine and on virus variant [39], so varying vaccination status also introduces variability into the susceptibility to infection.

Refer to caption
Figure 3: Plot of the probability of transmission of COVID-19, as a function of the length of contact time. The blue points are data from the work of Ferretti et al.  [22], using data from UK’s COVID-19 app [21]. Fit (blue) is obtained by fitting a straight line to logs of the data, and fit parameters are slope (exponent) 0.47±0.01plus-or-minus0.470.010.47\pm 0.010.47 ± 0.01 and intercept 3.63.6-3.6- 3.6. R2=0.996superscript𝑅20.996R^{2}=0.996italic_R start_POSTSUPERSCRIPT 2 end_POSTSUPERSCRIPT = 0.996. Ferretti et al.  [22] also fitted a power law to data and found the same value for the exponent β𝛽\betaitalic_β. Data has dynamic range of three decades in time (minutes to tens of hours). Also shown are predictions for PTsubscript𝑃𝑇P_{T}italic_P start_POSTSUBSCRIPT italic_T end_POSTSUBSCRIPT when: one susceptible person wears a surgical mask (green dashed), one person wears an FFP2/N95 (orange dashed), when the whole population wears surgical masks (solid green), and when the population wears FFP2/N95s (solid orange).

II.4 Overdispersion

Finally, we comment that the that the transmission of COVID-19 is known to be overdispersed[40, 41]. Overdispersion is a term in epidemiology that refers to the width of the distribution of NIsubscript𝑁𝐼N_{I}italic_N start_POSTSUBSCRIPT italic_I end_POSTSUBSCRIPT: the number of people infected by one infectious person. The standard model in epidemiology is that NIsubscript𝑁𝐼N_{I}italic_N start_POSTSUBSCRIPT italic_I end_POSTSUBSCRIPT follows a Poisson distribution. But if the distribution of NIsubscript𝑁𝐼N_{I}italic_N start_POSTSUBSCRIPT italic_I end_POSTSUBSCRIPT is broader than a Poisson then the disease transmission is said to be overdispersed [41]

A broad distribution of infectiousness in infected people, for example due to a broad distribution of viral loads, provides a natural explanation for overdispersion. Or to reverse the argument, the observed overdispersion is consistent with highly variable effective transmission rates. However, there are other factors in transmission, for example the number of contacts of a person is itself overdispersed in the sense of being broader than a Poisson distribution [42]. So any variability in transmission rate for a single contact is likely to be only one factor behind overdispersion.

III Data on the probability of infection as a function of time

So we expect that the transmission rate r𝑟ritalic_r varies over orders of magnitude. We now turn to data from the United Kingdom’s National Health Service (NHS) COVID-19 app [21]. During the COVID-19 pandemic, this app ran on users’ mobile phones and used Bluetooth to detect other users’ mobile phones when they were nearby. So it could estimate the length of a contact between two app users. Users also reported infections via the app. So both the duration of contacts and the probability of transmission can be estimated. See Kendall et al.  [21] and Ferretti et al.  [22] for further details.

The data from the NHS app was analysed by Ferretti et al.  [22], resulting in a plot of the probability of infection as a function of time, see Fig. 3 and Ferretti et al.  [22]. The measured probability of transmission PTsubscript𝑃𝑇P_{T}italic_P start_POSTSUBSCRIPT italic_T end_POSTSUBSCRIPT is plotted in Fig. 3. It is a particular population average: an average over the population of NHS app users in the UK during the period of operation of the app during the pandemic. This is data from 7 million contacts and 240,000 positive COVID-19 tests [22].

As Ferretti and coworkers [22] found, the data is well fit by a power law with exponent that is close to one half. By well fit we mean that the fractional error (residual) in the fit is typically 10% or less.

IV Wells-Riley model for infection probabilities in the presence of highly variable transmission rates

We now return to the model for transmission, Eq. (1). This gives the probability of transmission when there is one transmission rate r𝑟ritalic_r. If there is a distribution p(r)𝑝𝑟p(r)italic_p ( italic_r ) of the rates r𝑟ritalic_r, the probability of transmission is the Laplace transform of the distribution p(r)𝑝𝑟p(r)italic_p ( italic_r )

PT(t)=10p(r)exp(rt)drsubscript𝑃𝑇𝑡1superscriptsubscript0𝑝𝑟𝑟𝑡differential-d𝑟P_{T}(t)=1-\int_{0}^{\infty}p\left(r\right)\exp(-rt){\rm d}ritalic_P start_POSTSUBSCRIPT italic_T end_POSTSUBSCRIPT ( italic_t ) = 1 - ∫ start_POSTSUBSCRIPT 0 end_POSTSUBSCRIPT start_POSTSUPERSCRIPT ∞ end_POSTSUPERSCRIPT italic_p ( italic_r ) roman_exp ( - italic_r italic_t ) roman_d italic_r (2)

Here the probability density function p(r)𝑝𝑟p(r)italic_p ( italic_r ) gives the probability that in a population a contact between an infected and a susceptible person, has a transmission rate r𝑟ritalic_r.

If the distribution p(r)𝑝𝑟p(r)italic_p ( italic_r ) is sharply peaked at some characteristic rate rsuperscript𝑟r^{*}italic_r start_POSTSUPERSCRIPT ∗ end_POSTSUPERSCRIPT, then PT(t)subscript𝑃𝑇𝑡P_{T}(t)italic_P start_POSTSUBSCRIPT italic_T end_POSTSUBSCRIPT ( italic_t ) is close to the simple Poisson statistics model of Eq. (1). This is linear at short times — not what is observed in Fig. 3. In fact any relatively narrow distribution (no heavy/fat tails) of rates, such as the beta distribution used by Haas and coworkers and by others [1, 2], will give a PT(t)subscript𝑃𝑇𝑡P_{T}(t)italic_P start_POSTSUBSCRIPT italic_T end_POSTSUBSCRIPT ( italic_t ) that is linear at short times.

IV.1 Broad (fat-tailed) distributions of transmission rates

Very broad distributions are often modelled as power laws [17, 18, 43]. This motivates us to consider a power law distribution of transmission rates r𝑟ritalic_r with an exponent x𝑥xitalic_x,

p(r)rxrrMEDformulae-sequencesimilar-to𝑝𝑟superscript𝑟𝑥much-greater-than𝑟subscript𝑟𝑀𝐸𝐷p(r)\sim r^{-x}~{}~{}~{}~{}~{}r\gg r_{MED}italic_p ( italic_r ) ∼ italic_r start_POSTSUPERSCRIPT - italic_x end_POSTSUPERSCRIPT italic_r ≫ italic_r start_POSTSUBSCRIPT italic_M italic_E italic_D end_POSTSUBSCRIPT (3)

for rMEDsubscript𝑟𝑀𝐸𝐷r_{MED}italic_r start_POSTSUBSCRIPT italic_M italic_E italic_D end_POSTSUBSCRIPT the median rate. Here we are only assuming the rates follow a power law in the large rate tail of the distribution (as seen for the viral loads in Fig. 2).

Johnston [16] has studied the Laplace transforms of distributions p(r)𝑝𝑟p(r)italic_p ( italic_r ) with power laws. Applying his results here, we find that distributions p(r)𝑝𝑟p(r)italic_p ( italic_r ) with power law tails with x<2𝑥2x<2italic_x < 2 lead to a power law probability of transmission (at the low probabilities of transmission of Fig. 3)

PT(t)(rt)βat short timessimilar-tosubscript𝑃𝑇𝑡superscriptsuperscript𝑟𝑡𝛽at short timesP_{T}(t)\sim(r^{*}t)^{\beta}~{}~{}~{}\mbox{at short times}italic_P start_POSTSUBSCRIPT italic_T end_POSTSUBSCRIPT ( italic_t ) ∼ ( italic_r start_POSTSUPERSCRIPT ∗ end_POSTSUPERSCRIPT italic_t ) start_POSTSUPERSCRIPT italic_β end_POSTSUPERSCRIPT at short times (4)

with rsuperscript𝑟r^{*}italic_r start_POSTSUPERSCRIPT ∗ end_POSTSUPERSCRIPT a rate scale parameter and β=x1𝛽𝑥1\beta=x-1italic_β = italic_x - 1.

The data of Ferretti et al.  [22] is consistent with a power law with exponent β=0.47𝛽0.47\beta=0.47italic_β = 0.47. Therefore their data for COVID-19 transmission is consistent with the Wells-Riley model for transmission, with a power law distribution of transmission rates with exponent x=β+1=1.47𝑥𝛽11.47x=\beta+1=1.47italic_x = italic_β + 1 = 1.47.

Johnston [16] studied complete PTsubscript𝑃𝑇P_{T}italic_P start_POSTSUBSCRIPT italic_T end_POSTSUBSCRIPT’s that were stretched exponentials, i.e.,

PT(t)=1exp[(rt)β]subscript𝑃𝑇𝑡1superscriptsuperscript𝑟𝑡𝛽P_{T}(t)=1-\exp\left[-(r^{*}t)^{\beta}\right]italic_P start_POSTSUBSCRIPT italic_T end_POSTSUBSCRIPT ( italic_t ) = 1 - roman_exp [ - ( italic_r start_POSTSUPERSCRIPT ∗ end_POSTSUPERSCRIPT italic_t ) start_POSTSUPERSCRIPT italic_β end_POSTSUPERSCRIPT ] (5)

which give the power law behaviour in (4) at short times/low PTsubscript𝑃𝑇P_{T}italic_P start_POSTSUBSCRIPT italic_T end_POSTSUBSCRIPT. See Appendix B for the full distribution p(r)𝑝𝑟p(r)italic_p ( italic_r ) for x=3/2𝑥32x=3/2italic_x = 3 / 2 that gives rise to a stretched exponential. Note that as we only have data at low transmission probabilities, we can infer the large rate tail of p(r)𝑝𝑟p(r)italic_p ( italic_r ) but have little information on the behaviour of p(r)𝑝𝑟p(r)italic_p ( italic_r ) at low rates.

It is worth noting that the Wells-Riley model assumes that the probability of remaining uninfected decays exponentially, equivalent to assuming that the transmission rate r𝑟ritalic_r is not changing with time. This is clearly an approximation. The rate should vary whenever either the infected or susceptible person moves, for example farther apart or closer together. And the measured viral load varies from one day to the next [26, 10, 44]. However, the exponential dependence for a single contact should be a reasonable approximation so long as for most contacts there is fairly well defined timescale for transmission.

A final point to note is that the rate of increase of PT(t)subscript𝑃𝑇𝑡P_{T}(t)italic_P start_POSTSUBSCRIPT italic_T end_POSTSUBSCRIPT ( italic_t ) with time is decreasing, its first derivative with respect to time scales as tβ1superscript𝑡𝛽1t^{\beta-1}italic_t start_POSTSUPERSCRIPT italic_β - 1 end_POSTSUPERSCRIPT. As we have known since the work of Proschan in the 1960s [45] (on different systems), this is characteristic of systems where each one (here each contact) obeys Poisson statistics, but each system has a different rate. As Proschan [45] pointed out, the reason for this is simple. At early times the rate of increase of PIsubscript𝑃𝐼P_{I}italic_P start_POSTSUBSCRIPT italic_I end_POSTSUBSCRIPT is dominated by contacts with high transmission rates, so at these early times, PTsubscript𝑃𝑇P_{T}italic_P start_POSTSUBSCRIPT italic_T end_POSTSUBSCRIPT increases rapidly. But at longer times, transmission has already occurred for these high-transmission-rate contacts, so at these longer times they do not contribute to the increasing PTsubscript𝑃𝑇P_{T}italic_P start_POSTSUBSCRIPT italic_T end_POSTSUBSCRIPT. At these longer times, transmission is dominated by contacts with slower rates, and so the rate of increase of PTsubscript𝑃𝑇P_{T}italic_P start_POSTSUBSCRIPT italic_T end_POSTSUBSCRIPT with time is slower.

V Model for the effect of NPIs

Now that we have a model for the distribution of transmission rates, Eq. (3), we can develop a simple predictive model for the effect of an NPI. We assume that an NPI removes/filters out a fraction (1f)1𝑓(1-f)( 1 - italic_f ) of the virus and so scales all transmission rates r𝑟ritalic_r by a factor f𝑓fitalic_f, i.e.,

rNPIfrNPI𝑟𝑓𝑟r\xrightarrow{\text{NPI}}fritalic_r start_ARROW overNPI → end_ARROW italic_f italic_r (6)

This then simply scales the rate-scale parameter rsuperscript𝑟r^{*}italic_r start_POSTSUPERSCRIPT ∗ end_POSTSUPERSCRIPT by a factor f𝑓fitalic_f and, then using Eq. (4)

PTNPI(t)(frt)βfβPI(t)at short times, i.e., small PTformulae-sequencesimilar-tosuperscriptsubscript𝑃𝑇𝑁𝑃𝐼𝑡superscript𝑓superscript𝑟𝑡𝛽similar-tosuperscript𝑓𝛽subscript𝑃𝐼𝑡at short times, i.e., small PTP_{T}^{NPI}(t)\sim(fr^{*}t)^{\beta}\sim f^{\beta}P_{I}(t)~{}~{}~{}~{}\mbox{at % short times, i.e., small $P_{T}$}italic_P start_POSTSUBSCRIPT italic_T end_POSTSUBSCRIPT start_POSTSUPERSCRIPT italic_N italic_P italic_I end_POSTSUPERSCRIPT ( italic_t ) ∼ ( italic_f italic_r start_POSTSUPERSCRIPT ∗ end_POSTSUPERSCRIPT italic_t ) start_POSTSUPERSCRIPT italic_β end_POSTSUPERSCRIPT ∼ italic_f start_POSTSUPERSCRIPT italic_β end_POSTSUPERSCRIPT italic_P start_POSTSUBSCRIPT italic_I end_POSTSUBSCRIPT ( italic_t ) at short times, i.e., small italic_P start_POSTSUBSCRIPT italic_T end_POSTSUBSCRIPT (7)

We predict that when an NPI that reduces the transmission rates by a factor f𝑓fitalic_f is applied, the probability of infection scales by a factor fβsuperscript𝑓𝛽f^{\beta}italic_f start_POSTSUPERSCRIPT italic_β end_POSTSUPERSCRIPT. For the population of NHS app users, β1/2similar-to-or-equals𝛽12\beta\simeq 1/2italic_β ≃ 1 / 2. As β<1𝛽1\beta<1italic_β < 1 this is a sublinear reduction in risk, you need to reduce the expected dose by a factor of approximately four to reduce the risk by a factor of two.

It is worth noting that to make predictions for the effect of an NPI, we need a model for transmission, which necessarily makes assumptions. An empirical fit such as the power-law fit in Fig. 3 fixes a parameter value (β𝛽\betaitalic_β) in a fit but the fit itself is not enough. We need to assume: 1) the transmission probability for an individual contact obeys Poisson statistics, and 2) we are observing an average of a population of (independent) individual contacts where the rate r𝑟ritalic_r varies from one contact to another. Then the fit allows us to estimate the distribution of these rates. We then make assumption 3) that the NPI reduces the expected transmission rate of all contacts by a factor of f𝑓fitalic_f. Only then can we make an approximate prediction for the effect of an NPI.

V.1 Estimate for reduction in risk due to FFP2s/N95s and surgical masks

One NPI is the wearing of masks such as N95 or FFP2 masks [11]. N95 masks have been assigned a protection factor of 10, i.e., f=0.1𝑓0.1f=0.1italic_f = 0.1 [15]. The FFP2 standard is for a filtration efficiency of 92% as worn [14, 13]. Taking an FFP2/N95 to reduce the dose by a factor of f=0.1𝑓0.1f=0.1italic_f = 0.1 we can estimate PT(t)subscript𝑃𝑇𝑡P_{T}(t)italic_P start_POSTSUBSCRIPT italic_T end_POSTSUBSCRIPT ( italic_t ) for a person who is a member of a population equivalent to that of the NHS app users, when this person wears an FFP2/N95. This is the orange dashed line in Fig. 3. The prediction is that for contacts of all durations, the reduction in risk due to wearing an FFP2/N95 is by a factor of approximately three.

If the entire population dons FFP2/N95 masks the air is filtered twice, on exhaling and inhaling. The filtering efficiency should be approximately the same in both directions, so now f=0.12=0.01𝑓superscript0.120.01f=0.1^{2}=0.01italic_f = 0.1 start_POSTSUPERSCRIPT 2 end_POSTSUPERSCRIPT = 0.01. Then the reduction in risk is by approximately a factor of 1/0.010.479similar-to-or-equals1superscript0.010.4791/0.01^{0.47}\simeq 91 / 0.01 start_POSTSUPERSCRIPT 0.47 end_POSTSUPERSCRIPT ≃ 9. This is the solid orange line in Fig. 3.

Surgical masks are not only far less effective than FFP2/N95s, they are highly variable [13, 46, 15]. The FFP2 and N95 standards include requirements for filtration efficiency as worn but standards for surgical masks do not. Measured reductions in inhalation rate are by factors of 2.52.52.52.5 to 6.96.96.96.9 in the work of Oberg and Brosseau [46], and 1.71.71.71.7 to 3.63.63.63.6 in the work of Duncan et al.  [15]. If we take a factor of three then this gives a reduction in risk of (1/3)0.470.6similar-to-or-equalssuperscript130.470.6(1/3)^{0.47}\simeq 0.6( 1 / 3 ) start_POSTSUPERSCRIPT 0.47 end_POSTSUPERSCRIPT ≃ 0.6. So we predict one person wearing a surgical mask gives a reduction in infection probability of about 40%, while a whole population wearing surgical masks reduces transmission by about 60%. These predictions are shown as the dashed and solid green lines in Fig. 3.

V.1.1 Effect of NPI on effective reproduction number

In epidemiology, transmission of an infectious disease is often quantified by the effective reproduction number, which is the average number of infections caused by a single infected person [47, 48, 49]. It is usually denoted by R𝑅Ritalic_R (or Rtsubscript𝑅𝑡R_{t}italic_R start_POSTSUBSCRIPT italic_t end_POSTSUBSCRIPT). For an NPI that reduces the inhaled dose by a constant fraction f𝑓fitalic_f then as the transmission rate is predicted to drop by the constant fraction fβsuperscript𝑓𝛽f^{\beta}italic_f start_POSTSUPERSCRIPT italic_β end_POSTSUPERSCRIPT, then the effective reproduction number R𝑅Ritalic_R is also predicted to scale by the same factor, i.e.,

RNPIfβRNPI𝑅superscript𝑓𝛽𝑅R\xrightarrow{\text{NPI}}f^{\beta}Ritalic_R start_ARROW overNPI → end_ARROW italic_f start_POSTSUPERSCRIPT italic_β end_POSTSUPERSCRIPT italic_R (8)

So if a population dons FFP2/N95 masks, then as above f=0.01𝑓0.01f=0.01italic_f = 0.01 and so R𝑅Ritalic_R should be reduced by a factor of about nine.

V.2 Testing the prediction

There have been both observational studies and randomised controlled trials (RCTs) of the number of COVID-19 infections in those wearing masks, see the recent review of Boulos et al.   [50]. However, there is considerable scatter in the sizes of the effects found in these studies [50]. The studies all suffer from some combination of methodological problems [50] and small sample size (so large statistical error bars) [50]. In addition, the analysis of the data is subtle and controversial [51].

So, the RCTs and observational studies neither disprove the prediction nor strongly support the prediction made here. RCTs of mask use are challenging. They require a large population (to obtain small statistical error bars) to be split into two, with one half always wearing FFP2/N95 masks during any exposure, while otherwise behaving identically to the unmasked control group. As they are so challenging, we may have to rely on predictions such as that obtained here.

VI Conclusion

In conclusion, I have predicted that for a population like that of the UK, wearing FFP2/N95-type masks should reduce the effective reproduction number R𝑅Ritalic_R by a factor of nine. This relies on the COVID-19 app data, where there is an approximately square-root dependence of the probability of transmission [22], on the length of time of a contact between an infected and a susceptible person. This sublinear dependence on time can be interpreted as due to the transmission rate varying widely between one contact and another. Roughly speaking, the probability of transmission after, for example, a contact of 2 hours, is set by the fraction of contacts where the transmission rate is high enough to drive transmission in 2 hours or less. Then mask use reduces the inhaled doses and so scales up the time needed for transmission, such that a smaller fraction of contacts are long enough for transmission.

I have focused on one NPI for airborne transmission: masks/respirators. Another NPI is improving indoor air quality, as Morawska et al.  [30] have recently called for. This work suggests that, for example, doubling the rate of turnover of air should reduce transmission by approximately 11/230%similar-to112percent301-1/\sqrt{2}\sim 30\%1 - 1 / square-root start_ARG 2 end_ARG ∼ 30 %. This estimate is highly approximate but as obtaining population-level data on the effect of NPIs is so hard to do, this estimate may still be useful.

Acknowledgement This work relies on the data collected by the NHS COVID app [21, 22], so thank you to those who analysed the data and all who used this app. I also acknowledge that this work also relied on the data of Takatsuki et al.  [23] and Killingley et al.  [26].

Supplemental Material This is a Python Jupyter notebook that performs all the calculations in this work. This is available as XXX.

Appendix A Approximately linear relationship between a measurement of viable virus and qPCR measurement

Refer to caption
Figure 4: Plot of log10(\log_{10}(roman_log start_POSTSUBSCRIPT 10 end_POSTSUBSCRIPT (qPCR)))) as a function of log10(\log_{10}(roman_log start_POSTSUBSCRIPT 10 end_POSTSUBSCRIPT (FFA)))), data is from Killingley et al.  [26]. Their extended data Fig. 2(b), from throat swabs of people infected with COVID-19.

Killingley et al.  [26] find an approximately linear relationship between the quantity of viable virus and a qPCR measurement, for samples taken from the throat. Viable virus is measured by a focus-forming assay (FFA) [26]. Their data and a fit are in Fig. 4. The fit of a straight line to log data gives an exponent of 0.89±0.13plus-or-minus0.890.130.89\pm 0.130.89 ± 0.13, so close to a simple linear dependence. But note that the relationship may vary through the time course of an infection [52, 44, 10].

There is some evidence for a correlation between transmission, and the viral load some time after transmission, see the review of Puhach et al.   [25]. Note that we almost never know the viral load at the time transmission occurs, because the fact that transmission has occurred is only determined later. The viral load varies greatly during the course of an infection [25].

Refer to caption
Figure 5: (a) Plot of the probability distribution function of transmission rates, p(r/r)𝑝𝑟superscript𝑟p(r/r^{*})italic_p ( italic_r / italic_r start_POSTSUPERSCRIPT ∗ end_POSTSUPERSCRIPT ), Eq. (9), that yields a stretched exponential PT(t)subscript𝑃𝑇𝑡P_{T}(t)italic_P start_POSTSUBSCRIPT italic_T end_POSTSUBSCRIPT ( italic_t ) with exponent β=1/2𝛽12\beta=1/2italic_β = 1 / 2 [16]. (b) Plot of the probability distribution function of transmission timescales τ𝜏\tauitalic_τ, p(rτ)𝑝superscript𝑟𝜏p(r^{*}\tau)italic_p ( italic_r start_POSTSUPERSCRIPT ∗ end_POSTSUPERSCRIPT italic_τ ), Eq. (11), that yields a stretched exponential PT(t)subscript𝑃𝑇𝑡P_{T}(t)italic_P start_POSTSUBSCRIPT italic_T end_POSTSUBSCRIPT ( italic_t ) with exponent β=1/2𝛽12\beta=1/2italic_β = 1 / 2 [19, 20]. In both (a) and (b) the shaded regions are the only parts of the distribution relevant to the range of times (tens of minutes to tens of hours) for which the NHS app provides data.

Appendix B A stretched-exponential function with an exponent of one half is the Laplace transform of a distribution of rates with a large-rate tail scaling as r3/2superscript𝑟32r^{-3/2}italic_r start_POSTSUPERSCRIPT - 3 / 2 end_POSTSUPERSCRIPT

The probability density function p(s)𝑝𝑠p(s)italic_p ( italic_s ) that produces a stretched exponential exp[(rt)β]superscriptsuperscript𝑟𝑡𝛽\exp\left[(-r^{*}t)^{\beta}\right]roman_exp [ ( - italic_r start_POSTSUPERSCRIPT ∗ end_POSTSUPERSCRIPT italic_t ) start_POSTSUPERSCRIPT italic_β end_POSTSUPERSCRIPT ] with exponent β=1/2𝛽12\beta=1/2italic_β = 1 / 2 is [16]

p(s)=exp(1/s)4πs3𝑝𝑠1𝑠4𝜋superscript𝑠3p(s)=\frac{\exp\left(-1/s\right)}{\sqrt{4\pi s^{3}}}italic_p ( italic_s ) = divide start_ARG roman_exp ( - 1 / italic_s ) end_ARG start_ARG square-root start_ARG 4 italic_π italic_s start_POSTSUPERSCRIPT 3 end_POSTSUPERSCRIPT end_ARG end_ARG (9)

with s=r/r𝑠𝑟superscript𝑟s=r/r^{*}italic_s = italic_r / italic_r start_POSTSUPERSCRIPT ∗ end_POSTSUPERSCRIPT, and rsuperscript𝑟r^{*}italic_r start_POSTSUPERSCRIPT ∗ end_POSTSUPERSCRIPT a characteristic rate. This p(s)𝑝𝑠p(s)italic_p ( italic_s ) is plotted as Fig. 5(a). The median reduced rate s𝑠sitalic_s is sMED1.1similar-to-or-equalssubscript𝑠𝑀𝐸𝐷1.1s_{MED}\simeq 1.1italic_s start_POSTSUBSCRIPT italic_M italic_E italic_D end_POSTSUBSCRIPT ≃ 1.1 so the median rate rMED1.1rsimilar-to-or-equalssubscript𝑟𝑀𝐸𝐷1.1superscript𝑟r_{MED}\simeq 1.1r^{*}italic_r start_POSTSUBSCRIPT italic_M italic_E italic_D end_POSTSUBSCRIPT ≃ 1.1 italic_r start_POSTSUPERSCRIPT ∗ end_POSTSUPERSCRIPT [16].

Note the power law behaviour s3/2superscript𝑠32s^{-3/2}italic_s start_POSTSUPERSCRIPT - 3 / 2 end_POSTSUPERSCRIPT, for Eq. (9) when s1much-greater-than𝑠1s\gg 1italic_s ≫ 1. So as Ferretti et al.  [22]’s data is consistent with the low-infection-probability/short-time part of a stretched exponential with exponent near one half, it is consistent with a distribution of rates with a large-rate tail scaling approximately as r3/2superscript𝑟32r^{-3/2}italic_r start_POSTSUPERSCRIPT - 3 / 2 end_POSTSUPERSCRIPT. Ke et al.  [52] showed that a stretched exponential provides a good fit to data on infecting cell cultures as a function of (PCR-measured) viral load, with exponent β𝛽\betaitalic_β values similar to here, i.e., around one half.

However, note that the p(r)𝑝𝑟p(r)italic_p ( italic_r ) in Eq. (9) has a small-rate cutoff at s𝑠sitalic_s of order one, i.e., there are few rates much below the median rate, as we can see in Fig. 5(a). The lack of rates much below the median is why the stretched exponential tends to one for times longer than 1/r1superscript𝑟1/r^{*}1 / italic_r start_POSTSUPERSCRIPT ∗ end_POSTSUPERSCRIPT. In contrast, the infection probability of Ferretti et al.  is only PT1/4less-than-or-similar-tosubscript𝑃𝑇14P_{T}\lesssim 1/4italic_P start_POSTSUBSCRIPT italic_T end_POSTSUBSCRIPT ≲ 1 / 4 at around 100 hours.

So although the large rate tail of the distribution of Eq. (9) and Fig. 5(a) (large rate tail is shaded in the figure) is consistent with the experimental data, presumably the low rate parts differ. The fact that Ferretti et al.  have maximum values of PTsubscript𝑃𝑇P_{T}italic_P start_POSTSUBSCRIPT italic_T end_POSTSUBSCRIPT around one quarter not one within the tens of hours they measure implies that the effective transmission rate for three quarters of contacts is somewhere in the range zero to 102superscript10210^{-2}10 start_POSTSUPERSCRIPT - 2 end_POSTSUPERSCRIPTh-1. Finally, note that what is measured here is reported (via the app) infections, so for example if a person as infected but showed few or no symptoms they may not realise they are infected and so not report it. See Ferretti et al.  [22] for a discussion.

This is all for a distribution of rates. We can also write PTsubscript𝑃𝑇P_{T}italic_P start_POSTSUBSCRIPT italic_T end_POSTSUBSCRIPT as a distribution not of transmission rates r𝑟ritalic_r but of transmission timescales τ𝜏\tauitalic_τ, as

PT(t)=0p(τ)[1exp(t/τ)]dτsubscript𝑃𝑇𝑡superscriptsubscript0𝑝𝜏delimited-[]1𝑡𝜏differential-d𝜏P_{T}(t)=\int_{0}^{\infty}p\left(\tau\right)\left[1-\exp(-t/\tau)\right]{\rm d}\tauitalic_P start_POSTSUBSCRIPT italic_T end_POSTSUBSCRIPT ( italic_t ) = ∫ start_POSTSUBSCRIPT 0 end_POSTSUBSCRIPT start_POSTSUPERSCRIPT ∞ end_POSTSUPERSCRIPT italic_p ( italic_τ ) [ 1 - roman_exp ( - italic_t / italic_τ ) ] roman_d italic_τ (10)

Then an exponent β=1/2𝛽12\beta=1/2italic_β = 1 / 2 corresponds to the distribution of transmission timescales [19, 20]

p(q)=exp((1/4)q)4πq𝑝𝑞14𝑞4𝜋𝑞p(q)=\frac{\exp\left(-(1/4)q\right)}{\sqrt{4\pi q}}italic_p ( italic_q ) = divide start_ARG roman_exp ( - ( 1 / 4 ) italic_q ) end_ARG start_ARG square-root start_ARG 4 italic_π italic_q end_ARG end_ARG (11)

for q=rτ𝑞superscript𝑟𝜏q=r^{*}\tauitalic_q = italic_r start_POSTSUPERSCRIPT ∗ end_POSTSUPERSCRIPT italic_τ, i.e., the transmission timescale for a contact τ𝜏\tauitalic_τ in units of the characteristic timescale 1/r1superscript𝑟1/r^{*}1 / italic_r start_POSTSUPERSCRIPT ∗ end_POSTSUPERSCRIPT.

We have plotted p(q)𝑝𝑞p(q)italic_p ( italic_q ) in Fig. 5(B). Note the broad distribution of characteristic timescales τ𝜏\tauitalic_τ. As we should expect, whether we view transmission is being due to a distribution of transmission rates or timescales, then the distributions we find are very broad.

References

  • Haas [2015] C. N. Haas, Microbial dose response modeling: Past, present, and future, Environmental Sci. Tech. 49, 1245 (2015).
  • Sze To and Chao [2010] G. N. Sze To and C. Y. H. Chao, Review and comparison between the Wells–Riley and dose-response approaches to risk assessment of infectious respiratory diseases, Indoor Air 20, 2 (2010).
  • Greenhalgh et al. [2021] T. Greenhalgh, J. L. Jimenez, K. A. Prather, Z. Tufekci, D. Fisman, and R. Schooley, Ten scientific reasons in support of airborne transmission of SARS-CoV-2, Lancet 397, 1603 (2021).
  • Pöhlker et al. [2023] M. L. Pöhlker, C. Pöhlker, O. O. Krüger, J.-D. Förster, T. Berkemeier, W. Elbert, J. Fröhlich-Nowoisky, U. Pöschl, G. Bagheri, E. Bodenschatz, J. A. Huffman, S. Scheithauer, and E. Mikhailov, Respiratory aerosols and droplets in the transmission of infectious diseases, Rev. Mod. Phys. 95, 045001 (2023).
  • Abkarian et al. [2020] M. Abkarian, S. Mendez, N. Xue, F. Yang, and H. A. Stone, Speech can produce jet-like transport relevant to asymptomatic spreading of virus, Proceedings of the National Academy of Sciences 117, 25237 (2020).
  • Adenaiye et al. [2021] O. O. Adenaiye, J. Lai, P. J. Bueno de Mesquita, F. Hong, S. Youssefi, J. German, S. H. S. Tai, B. Albert, M. Schanz, S. Weston, J. Hang, C. Fung, H. K. Chung, K. K. Coleman, N. Sapoval, T. Treangen, I. M. Berry, K. Mullins, M. Frieman, T. Ma, and U. o. M. S. R. G. Milton, Donald K, Infectious Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Exhaled Aerosols and Efficacy of Masks During Early Mild Infection, Clinical Infectious Diseases 75, e241 (2021).
  • Tan et al. [2023] K. S. Tan, S. W. X. Ong, M. H. Koh, D. J. W. Tay, D. Z. H. Aw, Y. W. Nah, M. R. B. Abdullah, K. K. Coleman, D. K. Milton, J. J. H. Chu, V. T. Chow, P. A. Tambyah, and K. W. Tham, SARS-CoV-2 Omicron variant shedding during respiratory activities, International Journal of Infectious Diseases 131, 19 (2023).
  • Jia et al. [2022] W. Jia, J. Wei, P. Cheng, Q. Wang, and Y. Li, Exposure and respiratory infection risk via the short-range airborne route, Building and Environment 219, 109166 (2022).
  • Archer et al. [2022] J. Archer, L. P. McCarthy, H. E. Symons, N. A. Watson, C. M. Orton, W. J. Browne, J. Harrison, B. Moseley, K. E. Philip, J. D. Calder, et al., Comparing aerosol number and mass exhalation rates from children and adults during breathing, speaking and singing, Interface Focus 12, 20210078 (2022).
  • Jones et al. [2021] T. C. Jones, G. Biele, B. Mühlemann, T. Veith, J. Schneider, J. Beheim-Schwarzbach, T. Bleicker, J. Tesch, M. L. Schmidt, L. E. Sander, F. Kurth, P. Menzel, R. Schwarzer, M. Zuchowski, J. Hofmann, A. Krumbholz, A. Stein, A. Edelmann, V. M. Corman, and C. Drosten, Estimating infectiousness throughout SARS-CoV-2 infection course, Science 373, eabi5273 (2021).
  • Greenhalgh et al. [2024] T. Greenhalgh, C. R. MacIntyre, M. G. Baker, S. Bhattacharjee, A. A. Chughtai, D. Fisman, M. Kunasekaran, A. Kvalsvig, D. Lupton, M. Oliver, E. Tawfiq, M. Ungrin, and J. Vipond, Masks and respirators for prevention of respiratory infections: a state of the science review, Clinical Microbiology Reviews 37, e00124 (2024).
  • Bagheri et al. [2021] G. Bagheri, B. Thiede, B. Hejazi, O. Schlenczek, and E. Bodenschatz, An upper bound on one-to-one exposure to infectious human respiratory particles, Proceedings of the National Academy of Sciences 118, e2110117118 (2021).
  • Robinson et al. [2022] J. F. Robinson, I. Rios de Anda, F. J. Moore, F. K. A. Gregson, J. P. Reid, L. Husain, R. P. Sear, and C. P. Royall, How effective are face coverings in reducing transmission of COVID-19?, Aerosol Science Technology 56, 473 (2022).
  • Zoller et al. [2021] J. Zoller, J. Meyer, and A. Dittler, A critical note on filtering-face-piece filtration efficiency determination applying EN 149, J. Aerosol Science 158, 105830 (2021).
  • Duncan et al. [2021] S. Duncan, P. Bodurtha, and S. Naqvi, N95 respirators, disposable procedure masks and reusable cloth face coverings: Total inward leakage and filtration efficiency of materials against aerosol, PloS ONE 16, e0258191 (2021).
  • Johnston [2006] D. Johnston, Stretched exponential relaxation arising from a continuous sum of exponential decays, Physical Review B 74, 184430 (2006).
  • Newman [2005] M. E. Newman, Power laws, Pareto distributions and Zipf’s law, Contemporary physics 46, 323 (2005).
  • Clauset et al. [2009] A. Clauset, C. R. Shalizi, and M. E. Newman, Power-law distributions in empirical data, SIAM review 51, 661 (2009).
  • Lindsey and Patterson [1980] C. P. Lindsey and G. D. Patterson, Detailed comparison of the Williams–Watts and Cole–Davidson functions, Journal Chemical Physics 73, 3348 (1980).
  • Wu and Jia [2016] J. Wu and Q. Jia, The heterogeneous energy landscape expression of KWW relaxation, Scientific reports 6, 20506 (2016).
  • Kendall et al. [2023] M. Kendall, D. Tsallis, C. Wymant, A. Di Francia, Y. Balogun, X. Didelot, L. Ferretti, and C. Fraser, Epidemiological impacts of the NHS COVID-19 app in England and Wales throughout its first year, Nature Communications 14, 858 (2023).
  • Ferretti et al. [2024] L. Ferretti, C. Wymant, J. Petrie, D. Tsallis, M. Kendall, A. Ledda, F. Di Lauro, A. Fowler, A. Di Francia, J. Panovska-Griffiths, et al., Digital measurement of SARS-CoV-2 transmission risk from 7 million contacts, Nature , 145–150 (2024).
  • Takatsuki et al. [2023] Y. Takatsuki, Y. Takahashi, J. Nakajima, Y. Iwasaki, K. Nagano, C. Tani-Sassa, S. Yuasa, S. Kanehira, K. Sonobe, Y. Nukui, H. Takeuchi, K. Tanimoto, Y. Tanaka, A. Kimura, N. Ichimura, and S. Tohda, Viral load of sars-cov-2 omicron ba.5 is lower than that of ba.2 despite the higher infectivity of ba.5, Immunity, Inflammation and Disease 11, e783 (2023).
  • Peng et al. [2022] Z. Peng, A. P. Rojas, E. Kropff, W. Bahnfleth, G. Buonanno, S. Dancer, J. Kurnitski, Y. Li, M. Loomans, L. Marr, L. Morawska, W. Nazaroff, C. Noakes, X. Querol, C. Sekhar, R. Tellier, T. Greenhalgh, L. Bourouiba, A. Boerstra, J. Tang, S. Miller, and J. Jimenez, Practical indicators for risk of airborne transmission in shared indoor environments and their application to covid-19 outbreaks, Environmental Science & Technology 56, 1125 (2022).
  • Puhach et al. [2023] O. Puhach, B. Meyer, and I. Eckerle, SARS-CoV-2 viral load and shedding kinetics, Nature Reviews Microbiology 21, 147 (2023).
  • Killingley et al. [2022] B. Killingley, A. J. Mann, M. Kalinova, A. Boyers, N. Goonawardane, J. Zhou, K. Lindsell, S. S. Hare, J. Brown, R. Frise, et al., Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults, Nature Medicine 28, 1031 (2022).
  • Giri et al. [2022] A. Giri, N. Biswas, D. L. Chase, N. Xue, M. Abkarian, S. Mendez, S. Saha, and H. A. Stone, Colliding respiratory jets as a mechanism of air exchange and pathogen transport during conversations, Journal of Fluid Mechanics 930, R1 (2022).
  • Bourouiba [2021a] L. Bourouiba, The fluid dynamics of disease transmission, Annual Review of Fluid Mechanics 53, 473 (2021a).
  • Bourouiba [2021b] L. Bourouiba, Fluid dynamics of respiratory infectious diseases, Annual Review of Biomedical Engineering 23, 547 (2021b), pMID: 34255991.
  • Morawska et al. [2024] L. Morawska, J. Allen, W. Bahnfleth, B. Bennett, P. M. Bluyssen, A. Boerstra, G. Buonanno, J. Cao, S. J. Dancer, A. Floto, F. Franchimon, T. Greenhalgh, C. Haworth, J. Hogeling, C. Isaxon, J. L. Jimenez, A. Kennedy, P. Kumar, J. Kurnitski, Y. Li, M. Loomans, G. Marks, L. C. Marr, L. Mazzarella, A. K. Melikov, S. L. Miller, D. K. Milton, J. Monty, P. V. Nielsen, C. Noakes, J. Peccia, K. A. Prather, X. Querol, T. Salthammer, C. Sekhar, O. Seppänen, S. ichi Tanabe, J. W. Tang, R. Tellier, K. W. Tham, P. Wargocki, A. Wierzbicka, and M. Yao, Mandating indoor air quality for public buildings, Science 383, 1418 (2024).
  • Oswin et al. [2022] H. P. Oswin, A. E. Haddrell, M. Otero-Fernandez, J. F. Mann, T. A. Cogan, T. G. Hilditch, J. Tian, D. A. Hardy, D. J. Hill, A. Finn, et al., The dynamics of SARS-CoV-2 infectivity with changes in aerosol microenvironment, Proceedings National Academy of Sciences 119, e2200109119 (2022).
  • Haddrell et al. [2023] A. Haddrell, M. Otero-Fernandez, H. Oswin, T. Cogan, J. Bazire, J. Tian, R. Alexander, J. F. Mann, D. Hill, A. Finn, et al., Differences in airborne stability of SARS-CoV-2 variants of concern is impacted by alkalinity of surrogates of respiratory aerosol, J Royal Society Interface 20, 20230062 (2023).
  • Augusto et al. [2023] D. G. Augusto, L. D. Murdolo, D. S. Chatzileontiadou, J. J. Sabatino Jr, T. Yusufali, N. D. Peyser, X. Butcher, K. Kizer, K. Guthrie, V. W. Murray, et al., A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection, Nature 620, 128 (2023).
  • Hill [2012] A. V. Hill, Evolution, revolution and heresy in the genetics of infectious disease susceptibility, Philosophical Transactions of the Royal Society B: Biological Sciences 367, 840 (2012).
  • van der Made et al. [2022] C. I. van der Made, M. G. Netea, F. L. van der Veerdonk, and A. Hoischen, Clinical implications of host genetic variation and susceptibility to severe or critical covid-19, Genome Medicine 14, 1 (2022).
  • Viner et al. [2021] R. M. Viner, O. T. Mytton, C. Bonell, G. J. Melendez-Torres, J. Ward, L. Hudson, C. Waddington, J. Thomas, S. Russell, F. van der Klis, A. Koirala, S. Ladhani, J. Panovska-Griffiths, N. G. Davies, R. Booy, and R. M. Eggo, Susceptibility to SARS-CoV-2 Infection Among Children and Adolescents Compared With Adults: A Systematic Review and Meta-analysis, JAMA Pediatrics 175, 143 (2021).
  • Shoham et al. [2023] S. Shoham, C. Batista, Y. B. Amor, O. Ergonul, M. Hassanain, P. Hotez, G. Kang, J. H. Kim, B. Lall, H. J. Larson, et al., Vaccines and therapeutics for immunocompromised patients with covid-19, eClinicalMedicine 59, 101965 (2023).
  • Paris [2023] R. Paris, SARS-CoV-2 Infection and Response to COVID-19 Vaccination in Patients With Primary Immunodeficiencies, Journal Infectious Diseases 228, S24 (2023).
  • Kaplonek et al. [2023] P. Kaplonek, D. Cizmeci, G. Kwatra, A. Izu, J. S.-L. Lee, H. L. Bertera, S. Fischinger, C. Mann, F. Amanat, W. Wang, et al., Chadox1 ncov-19 (azd1222) vaccine-induced fc receptor binding tracks with differential susceptibility to covid-19, Nature Immunology 24, 1161 (2023).
  • Chen et al. [2021] P. Z. Chen, M. Koopmans, D. N. Fisman, and F. X. Gu, Understanding why superspreading drives the COVID-19 pandemic but not the H1N1 pandemic, The Lancet Infectious Diseases 21, 1203 (2021).
  • Wegehaupt et al. [2023] O. Wegehaupt, A. Endo, and A. Vassall, Superspreading, overdispersion and their implications in the SARS-CoV-2 (COVID-19) pandemic: a systematic review and meta-analysis of the literature, BMC Public Health 23, 1 (2023).
  • Mossong et al. [2008] J. Mossong, N. Hens, M. Jit, P. Beutels, K. Auranen, R. Mikolajczyk, M. Massari, S. Salmaso, G. S. Tomba, J. Wallinga, J. Heijne, M. Sadkowska-Todys, M. Rosinska, and W. J. Edmunds, Social contacts and mixing patterns relevant to the spread of infectious diseases, PLOS Medicine 5, 1 (2008).
  • Stumpf and Porter [2012] M. P. H. Stumpf and M. A. Porter, Critical truths about power laws, Science 335, 665 (2012).
  • Kissler et al. [2021] S. M. Kissler, J. R. Fauver, C. Mack, S. W. Olesen, C. Tai, K. Y. Shiue, C. C. Kalinich, S. Jednak, I. M. Ott, C. B. Vogels, et al., Viral dynamics of acute SARS-CoV-2 infection and applications to diagnostic and public health strategies, PLoS biology 19, e3001333 (2021).
  • Proschan [1963] F. Proschan, Theoretical explanation of observed decreasing failure rate, Technometrics 5, 375 (1963).
  • Oberg and Brosseau [2008] T. Oberg and L. M. Brosseau, Surgical mask filter and fit performance, American Journal of Infection Control 36, 276 (2008).
  • Vegvari et al. [2022] C. Vegvari, S. Abbott, F. Ball, E. Brooks-Pollock, R. Challen, B. S. Collyer, C. Dangerfield, J. R. Gog, K. M. Gostic, J. M. Heffernan, T. D. Hollingsworth, V. Isham, E. Kenah, D. Mollison, J. Panovska-Griffiths, L. Pellis, M. G. Roberts, G. S. Tomba, R. N. Thompson, and P. Trapman, Commentary on the use of the reproduction number R during the COVID-19 pandemic, Statistical Methods Medical Research 31, 1675 (2022).
  • van den Driessche [2017] P. van den Driessche, Reproduction numbers of infectious disease models, Infectious Disease Modelling 2, 288 (2017).
  • Cori et al. [2013] A. Cori, N. M. Ferguson, C. Fraser, and S. Cauchemez, A New Framework and Software to Estimate Time-Varying Reproduction Numbers During Epidemics, American Journal Epidemiology 178, 1505 (2013).
  • Boulos et al. [2023] L. Boulos, J. A. Curran, A. Gallant, H. Wong, C. Johnson, A. Delahunty-Pike, L. Saxinger, D. Chu, J. Comeau, T. Flynn, J. Clegg, and C. Dye, Effectiveness of face masks for reducing transmission of SARS-CoV-2: a rapid systematic review, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences 381, 20230133 (2023).
  • Bar-Yam et al. [2023] Y. Bar-Yam, J. M. Samet, A. F. Siegenfeld, and N. N. Taleb, Quantitative errors in the cochrane review on ”physical interventions to interrupt or reduce the spread of respiratory viruses” (2023), arXiv:2310.15198 [physics.soc-ph] .
  • Ke et al. [2021] R. Ke, C. Zitzmann, D. D. Ho, R. M. Ribeiro, and A. S. Perelson, In vivo kinetics of sars-cov-2 infection and its relationship with a person’s infectiousness, Proceedings of the National Academy of Sciences 118, e2111477118 (2021).